Clinical Trial

A Study to Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Food

Name: A Study to Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Food — clinical trial record (NCT07404137)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to investigate the concentrations of zibotentan and dapagliflozin in blood when given with and without food in healthy participants.

Protocol Amendment History 1 change

critical Trial completed 2026-04-14

Trial Details

NCT Number	NCT07404137
Lead Sponsor	AstraZeneca
Conditions	Healthy Participants
Enrollment	26 participants
Start Date	2026-02-16
Primary Completion	2026-04-02 (estimated)
Study Completion	2026-04-02 (estimated)
Updated on ClinicalTrials.gov	2026-04-13